Trial Profile
Impact of Cytochrome P450 2C19*2 Polymorphism on Intra-Stent Thrombus After drug eluting stent Implantation Receiving Clopidogrel.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Coronary artery disease; Coronary stent thrombosis
- Focus Pharmacogenomic; Therapeutic Use
- 21 May 2019 Status changed from recruiting to completed.
- 31 May 2012 New trial record